Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06695845 |
| Consolidated Lead Sponsor | Jazz Pharmaceuticals |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 200 participants (ESTIMATED) |
| Registered Start Date | 2025-01-14 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Florida Cancer Specialists (Fort Myers) | Fort Myers, FL | Open Hospital Dossier -> |
| Florida Cancer Specialists (Saint Petersburg) | Saint Petersburg, FL | Open Hospital Dossier -> |
| Florida Cancer Specialists (West Palm Beach) | West Palm Beach, FL | Open Hospital Dossier -> |
| Barbara Ann Karmanos Cancer Institute | Detroit, MI | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Jazz Pharmaceuticals across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.